Search Results - "Tousignant, J D"
-
1
Binding and uptake of cationic lipid:pDNA complexes by polarized airway epithelial cells
Published in Human gene therapy (01-01-1999)“…To better understand the barriers associated with cationic lipid-mediated gene transfer to polarized epithelial cells, Fischer rat thyroid (FRT) cells and…”
Get more information
Journal Article -
2
Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice
Published in Human gene therapy (10-12-2000)“…A major limitation associated with systemic administration of cationic lipid:plasmid DNA (pDNA) complexes is the vector toxicity at the doses necessary to…”
Get more information
Journal Article -
3
Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG Motifs
Published in Molecular therapy (01-03-2000)“…An inflammatory response is invariably associated with administration of gene transfer complexes composed of cationic lipids and plasmid DNA (pDNA). In the…”
Get full text
Journal Article -
4
DNA sequences in cationic lipid:pDNA-mediated systemic toxicities
Published in Human gene therapy (10-02-2003)“…Systemic delivery of synthetic gene transfer vectors such as cationic lipid:plasmid DNA (pDNA) complexes elicits a range of acute physiologic responses, which…”
Get more information
Journal Article -
5
Partial correction of the α-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors
Published in The journal of gene medicine (01-01-2004)“…Background Fabry disease is a recessive, X‐linked disorder caused by a deficiency of the lysosomal enzyme α‐galactosidase A, leading to an accumulation of the…”
Get full text
Journal Article -
6
A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung
Published in Human gene therapy (10-04-1997)“…Advances in gene therapy vectors and techniques hold promise for treatment of many inherited and acquired diseases. For lung indications, especially those…”
Get more information
Journal Article -
7
Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes
Published in Human gene therapy (10-02-1997)“…We have examined several variables inherent in aerosolizing cationic lipid:DNA complexes using a jet nebulizer and thereby have optimized the delivery of…”
Get more information
Journal Article -
8
Aerosolization of cationic lipid:pDNA complexes--in vitro optimization of nebulizer parameters for human clinical studies
Published in Human gene therapy (01-01-1998)“…Previously, we have described the optimization of the aerosol delivery of a nonviral gene therapy vector to the lungs of rodents (Eastman et al., 1997b)…”
Get more information
Journal Article -
9
CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in Vivo
Published in Molecular therapy (01-06-2002)“…Systemic delivery of cationic lipid–plasmid DNA (pDNA) complexes induces an acute inflammatory response with adverse hematologic changes and liver damage…”
Get full text
Journal Article